These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24373621)
1. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452 [TBL] [Abstract][Full Text] [Related]
3. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma. Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216 [TBL] [Abstract][Full Text] [Related]
4. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma. Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115 [TBL] [Abstract][Full Text] [Related]
6. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417 [TBL] [Abstract][Full Text] [Related]
7. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population. Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540 [TBL] [Abstract][Full Text] [Related]
8. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers. Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells. Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888 [TBL] [Abstract][Full Text] [Related]
10. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001 [TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients. Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794 [TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma. Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572 [TBL] [Abstract][Full Text] [Related]
13. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs. Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821 [TBL] [Abstract][Full Text] [Related]
15. MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma. Hess AK; Müer A; Mairinger FD; Weichert W; Stenzinger A; Hummel M; Budach V; Tinhofer I Eur J Cancer; 2017 May; 77():3-12. PubMed ID: 28347920 [TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics. Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264 [TBL] [Abstract][Full Text] [Related]
17. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer. Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708 [TBL] [Abstract][Full Text] [Related]
18. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer. Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584 [TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]